United States: Teva v. Sandoz (USSC) – Standard for Appellate Review Of Claim Construction Rulings

On Jan. 20, 2015, the U.S. Supreme Court issued a decision setting forth a new standard for appellate review of a district court's claim construction ruling.  Teva Pharmas. USA, Inc. v. Sandoz, Inc., No. 13-854, slip op., 574 U.S. __ (2015).  Prior to this decision, a district court's claim construction ruling was reviewed de novo (from scratch) by the Federal Circuit. The Supreme Court held, by a 7-2 majority authored by Justice Breyer, that factual issues decided by a district court are to be reviewed for "clear error", while all other aspects of a claim construction ruling continue to be reviewed de novo.

In Teva, the dispute was over the meaning of the term "molecular weight."  Sandoz argued that the patent at issue was invalid because the term "molecular weight" was indefinite under 35 U.S.C. §112 ¶2 since it could have one of three meanings based on the specification.  The District Court, after taking evidence from experts, concluded that the patent claim was not indefinite.  It found that a person of ordinary skill in the art would understand the term "molecular weight" to refer to one of the three possible meanings.  On appeal, the Federal Circuit reviewed the claim construction de novo and reversed, holding that the term "molecular weight" was indefinite.

The majority opinion in Teva focused on Federal Rule of Civil Procedure 52(a)(6), which states that a court of appeals "must not...set aside" a district court's "[f]indings of fact" unless they are "clearly erroneous."  The Court held that this rule must apply when the Federal Circuit reviews a district court's resolution of a factual matters made in the course of its claim construction, even though claim construction is an issue of law.  According to the majority, a district court judge who presided over and listened to the case has a greater understanding of the facts at issue as opposed to a Federal Circuit judge who must read a written transcript (there are no live witnesses during a Federal Circuit appeal, only attorney argument based on legal briefs).  According to the majority, the underlining factual findings, and therefore the Teva standard, should have little impact on litigated claim constructions.

After specifying which standard applies, the Supreme Court's majority opinion went on to provide guidance on how the standard should be applied.  Specifically, the majority said that when the district court reviews only intrinsic evidence (the patent claim and specification, along with the patent prosecution history) that is a determination of law to be reviewed de novo.  However, in some cases, the district court will need to look beyond the intrinsic evidence and consult extrinsic evidence.  For example, a court, based on expert testimony and other extrinsic evidence, may need to understand the background science or  may need to make a factual finding that a term of art has a particular meaning to one of ordinary skill in the art at the time of the invention.  Such factual findings are subject to the "clear error" standard and should only be disturbed by the Federal Circuit if the district court's findings are clearly erroneous.

In the Teva case, the experts disagreed over an interpretation of a figure with respect to the term "molecular weight".  The District Court credited Teva's expert's interpretation over that of Sandoz's expert.  The District Court's conclusion on this issue was a factual finding about how a skilled artisan would understand the figure and this factual finding, according to the majority, should have been reviewed for clear error.  Since the Federal Circuit reviewed the entire claim construction, including this factual issue, de novo, the Supreme Court reversed the Federal Circuit's decision and remanded for further proceedings under this Teva standard.

The dissenting opinion was written by Justice Thomas and joined by Justice Alito.  The dissent argues that claim construction is a pure legal issue and therefore Rule 52(a)(6) does not apply.  According to the dissent, fact finding in claim construction more closely resembles fact finding underlying the construction of statutes or contracts and deeds, which are considered pure issues of law.  The dissent is concerned that the majority's decision will disturb the uniformity of claim construction and, contrary to the majority statement, will "loom large" in litigated claim construction. Specifically, the dissent is concerned that a party who prevails in a district court on a claim construction will argue on appeal that the district court's construction is based upon findings of fact and therefore should stand absent clear error.  The dissent is also concerned that there would be fewer precedential claim construction decisions by the Federal Circuit based on the new standard of review.

It remains to be seen what impact, the Teva decision will have on future litigation.  Specifically, litigants may be encouraged to add factual arguments (based on extrinsic evidence) to their intrinsic arguments in support of their claim construction positions so that, in the event they prevail, there is less of a likelihood that the district court's decision will be reversed by the federal circuit. This may lead to a heavier reliance on expert testimony and, as a result, increased costs and complexity with the claim construction proceeding.  Similarly, it remains to be seen whether district court judges will write their opinions in a way to rely more heavily on factual findings in order to reduce the chance of being reversed on appeal.  In this connection, a district court judge may have an evidentiary hearing as part of the claim construction process in order to resolve factual disputes.  If so, and if the construction hinges on factual findings, those findings would be reviewed for clear error under the new Teva standard.  As for the Federal Circuit, it will be interesting to see whether it will attempt to sidestep the Teva decision by focusing its review of a district court's claim construction on the non-factual aspects of the construction so that the clear error standard will not apply.  Post-Teva, the Federal Circuit must still consider the intrinsic and extrinsic evidence in reaching its claim construction as a matter of law.  However, the Federal Circuit might discount and effectively override the district court's extrinsic factual findings if it believes they are outweighed by the intrinsic evidence.

In short, it appears that the Teva decision provides opportunities for litigants, district courts, and the Federal Circuit, to support their claim construction positions in a way that increases the likelihood of success.  Thus, it will be interesting to see how the Teva decision plays out in future litigation.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
17 Jan 2018, Seminar, Los Angeles, United States

The annual PIHRA Legal Update Seminars provides you with the latest California employment law related updates, compliance and regulatory issues, and the opportunity to network with legal practitioners and HR professionals.

18 Jan 2018, Seminar, Seoul, South Korea

Please join Sheppard Mullin and Lee & Ko for a cutting-edge discussion on “Trends in Intellectual Property – Keep Up or Get Left Behind” in view of key IP law developments in the United States.

18 Jan 2018, Webinar, Los Angeles, United States

Please join Sheppard Mullin for this month's Third Thursday Emerging Company Webinar educating entrepreneurs and emerging companies on the key legal issues they face during the growth of their companies. These complimentary 1-hour webinars are held through WebEx on the third Thursday of the month at noon. They will have both an audio and PowerPoint component.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions